Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM98027 (US10472367, Compound Formula I | US10919901, Compo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Incyte Corporation US Patent | Assay Description The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity. | US Patent US8487096 (2013) BindingDB Entry DOI: 10.7270/Q2319THZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM98028 (US10472367, Compound Formula II | US10919901, Comp...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Incyte Corporation US Patent | Assay Description The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity. | US Patent US8487096 (2013) BindingDB Entry DOI: 10.7270/Q2319THZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM98031 (US10472367, Compound Formula V | US10919901, Compo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Incyte Corporation US Patent | Assay Description The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity. | US Patent US8487096 (2013) BindingDB Entry DOI: 10.7270/Q2319THZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM98030 (US10472367, Compound Formula IV | US10919901, Comp...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Incyte Corporation US Patent | Assay Description The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity. | US Patent US8487096 (2013) BindingDB Entry DOI: 10.7270/Q2319THZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM98029 (US10472367, Compound Formula III | US10919901, Com...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | 7.5 | 30 |
Incyte Corporation US Patent | Assay Description The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity. | US Patent US8487096 (2013) BindingDB Entry DOI: 10.7270/Q2319THZ | |||||||||||
More data for this Ligand-Target Pair |